Maksymowych, Walter P.
Inman, Robert D.
Bessette, Louis
Rahman, Proton
Rampakakis, Emmanouil
Asin-Milan, Odalis
Rachich, Meagan
Marrache, Anne Marilise
Lehman, Allen J.
Article History
Received: 2 November 2022
Accepted: 20 April 2023
First Online: 28 April 2023
Declarations
:
: Patients were required to provide written informed consent prior to enrollment in the study. Ethics approval was obtained by a central Research Ethics Board (IRB Services, Ontario, Canada) for private practices and respective Research Ethics Boards for institutional sites. BioTRAC was conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: WPM is Chief Medical Officer of CARE Arthritis Limited, has acted as a paid consultant/participated in advisory boards for AbbVie, Boehringer Ingelheim, Celgene, Eli Lilly, Galapagos, Janssen, Novartis, Pfizer and UCB; received research and/or educational grants from AbbVie, Novartis, Pfizer and UCB; and received speaker fees from AbbVie, Janssen, Novartis, Pfizer and UCB. RDI has acted as a consultant for Abbvie, Janssen, Lilly, Novartis, SandozĀ LB has acted as a speaker, consultant, and researcher for Amgen, BMS, Janssen, UCB, AbbVie, Pfizer, Merck, Lilly, Novartis, Sanofi. Speaker and consultant for Sandoz, Fresenius Kabi, and Teva. Consultant and researcher for Gilead. Researcher for Celgene. PR has received consulting fees from Abbott, AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Eli Lilly, Janssen, Novartis, and Pfizer, and has also received research grants from Janssen and Novartis. ER is an employee at JSS Medical Research. OA-M, MR, AMM, and AJL are employees at Janssen Inc.